Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about AND: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
🤖 AI-GeneratedNo AI portrait yet
Knowledge base pages for this entity
graph TD
subgraph Interactions["Interactions"]
AND["AND"] -->|"participates in"| oxidative_stress_response["oxidative stress response"]
AND["AND"] -->|"participates in"| apoptosis_pathway["apoptosis pathway"]
AND["AND"] -->|"interacts with"| Alzheimer_s_disease["Alzheimer's disease"]
AND["AND"] -->|"participates in"| ubiquitin_proteasome["ubiquitin-proteasome"]
TP53["TP53"] -->|"interacts with"| AND["AND"]
APOPTOSIS_2["APOPTOSIS"] -->|"interacts with"| AND["AND"]
end
subgraph Therapeutic["Therapeutic"]
AND["AND"] -->|"expressed in"| endothelial_cells["endothelial cells"]
end
subgraph Pathology["Pathology"]
AND["AND"] -->|"associated with"| Alzheimer_s_disease_1["Alzheimer's disease"]
AND["AND"] -->|"associated with"| neurodegeneration["neurodegeneration"]
AND["AND"] -->|"associated with"| PS1["PS1"]
AND["AND"] -->|"associated with"| Atherosclerosis["Atherosclerosis"]
MYC["MYC"] -->|"associated with"| AND["AND"]
JUN["JUN"] -->|"associated with"| AND["AND"]
APOPTOSIS["APOPTOSIS"] -->|"associated with"| AND["AND"]
end
subgraph Signaling["Signaling"]
CYTOKINES["CYTOKINES"] -->|"activates"| AND["AND"]
end
style AND fill:#90a4ae,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style oxidative_stress_response fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style apoptosis_pathway fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style endothelial_cells fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Alzheimer_s_disease fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Alzheimer_s_disease_1 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style neurodegeneration fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style PS1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style ubiquitin_proteasome fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Atherosclerosis fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style TP53 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MYC fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style JUN fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style APOPTOSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style CYTOKINES fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style APOPTOSIS_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:AND | data_in | dataset_row | 0.00 |
| genes-and | has_wiki | wiki_page | 1.00 |
| wp-3a5eaa1ed68d | has_wiki | wiki_page | 1.00 |
| oxidative stress response | participates_in | pathway | 0.90 |
| and | describes | gene | 0.90 |
| endothelial cells | expressed_in | cell_type | 0.80 |
| apoptosis pathway | participates_in | pathway | 0.80 |
| neurodegeneration | associated_with | disease | 0.70 |
| Alzheimer's disease | associated_with | disease | 0.70 |
| PS1 | associated_with | gene | 0.70 |
| Alzheimer's disease | interacts_with | disease | 0.70 |
| ubiquitin-proteasome | participates_in | pathway | 0.70 |
| Ischemia | inhibits | disease | 0.65 |
| Aging | inhibits | disease | 0.65 |
| Stroke | inhibits | disease | 0.65 |
| Longevity | activates | disease | 0.65 |
| Epilepsy | associated_with | disease | 0.65 |
| Neuropathy | associated_with | disease | 0.65 |
| Depression | regulates | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | therapeutic_target | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | interacts_with | disease | 0.65 |
| Sepsis | therapeutic_target | disease | 0.65 |
| Epilepsy | activates | disease | 0.65 |
| Ataxia | associated_with | disease | 0.65 |
| Rheumatoid Arthritis | associated_with | disease | 0.65 |
| Dementia | associated_with | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Hepatitis | associated_with | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Neurodegeneration | interacts_with | disease | 0.65 |
| Schizophrenia | regulates | disease | 0.65 |
| Huntington | activates | disease | 0.65 |
| Ischemia | therapeutic_target | disease | 0.65 |
| Dementia | therapeutic_target | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | expressed_in | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | inhibits | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Lupus | associated_with | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | regulates | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Ischemia | associated_with | disease | 0.65 |
| Neuroinflammation | associated_with | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Depression | associated_with | disease | 0.65 |
| Huntington | associated_with | disease | 0.65 |
| Traumatic Brain Injury | associated_with | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Vascular Dementia | associated_with | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:AND | data_in | dataset_row | 0.00 |
| genes-and | described_by | wiki_page | 1.00 |
| wp-3a5eaa1ed68d | described_by | wiki_page | 1.00 |
| and | describes | wiki | 0.90 |
| h-7d4a24d3 | targets | hypothesis | 0.80 |
| h-0758b337 | targets | hypothesis | 0.80 |
| h-db6aa4b1 | targets | hypothesis | 0.80 |
| DEPRESSION | associated_with | gene | 0.60 |
| PARKINSON | associated_with | gene | 0.60 |
| GPX4 | associated_with | gene | 0.60 |
| HO-1 | associated_with | gene | 0.60 |
| MICROGLIA | associated_with | gene | 0.60 |
| MAPK | associated_with | gene | 0.60 |
| NEUROINFLAMMATION | associated_with | gene | 0.60 |
| OXIDATIVE STRESS | associated_with | gene | 0.60 |
| CIRCADIAN RHYTHM | associated_with | gene | 0.60 |
| AGING | associated_with | gene | 0.60 |
| SYNAPTIC PRUNING | associated_with | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| SYNAPSE | associated_with | gene | 0.60 |
| AQP4 | associated_with | gene | 0.60 |
| NBR1 | associated_with | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | associated_with | gene | 0.60 |
| DNA | associated_with | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| AUTOPHAGY | associated_with | gene | 0.60 |
| MYELIN | associated_with | gene | 0.60 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.60 |
| TGM2 | associated_with | gene | 0.60 |
| CX43 | associated_with | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | associated_with | gene | 0.60 |
| MIRNAS | associated_with | gene | 0.60 |
| MITOPHAGY | associated_with | gene | 0.60 |
| AXON | associated_with | gene | 0.60 |
| GBM | associated_with | gene | 0.60 |
| BRAF | associated_with | gene | 0.60 |
| ANXIETY | associated_with | gene | 0.60 |
| AMYLOID-BETA | associated_with | gene | 0.60 |
| UBIQUITIN | associated_with | gene | 0.60 |
| PIK3CA | associated_with | gene | 0.60 |
| ALZHEIMER DISEASE | associated_with | gene | 0.60 |
| CATALASE | associated_with | gene | 0.60 |
| PRESENILIN | associated_with | gene | 0.60 |
| SORL1 | associated_with | gene | 0.60 |
| BIN1 | associated_with | gene | 0.60 |
| CASP4 | associated_with | gene | 0.60 |
| GAIN | associated_with | gene | 0.60 |
| NGF | associated_with | gene | 0.60 |
| GLA | associated_with | gene | 0.60 |
| SYN1 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Plant-based dietary patterns and Alzheimer's disease risk in multiethn | clinical | Alzheimer's disease and relate | 0.950 | 0.00 | human patients | proposed | N/A |
| MAPK pathway inhibition by QTJD through butyrate mechanism | exploratory | Mycoplasma pneumoniae pneumoni | 0.900 | 0.00 | Mouse macrophages | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and [PMID:38377788] | Kalyanaraman B, Cheng G, Hardy M | Redox biology | 2024 | 0 |
| P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting [PMID:38513667] | Zhang D, Zhang W, Ming C, Gao X, Yuan H, | Neuron | 2024 | 0 |
| The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disea [PMID:38852117] | Balusu S, De Strooper B | Acta neuropathologica | 2024 | 0 |
| Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease. [PMID:34069890] | Burillo J, Marqués P, Jiménez B, Gonzále | Cells | 2021 | 0 |
| Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in tra [PMID:17021169] | ["Oakley, Holly", "Cole, Sarah L", "Loga | The Journal of neuroscience : | 2006 | 0 |
| The amyloid hypothesis of Alzheimer's disease: progress and problems on the road [PMID:12130773] | ["Hardy, John", "Selkoe, Dennis J"] | Science (New York, N.Y.) | 2002 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning AND in their description or question text
Score: 0.896 · Alzheimer's disease · 2026-04-05
## Mechanistic Overview Closed-loop tACS targeting EC-II SST interneurons to block tau propagation and restore perforant
Score: 0.867 · Alzheimer's disease · 2026-04-07
## Mechanistic Overview Closed-loop tACS targeting EC-II PV interneurons to enhance perisomatic inhibition and block tau
Score: 0.863 · Alzheimer's disease · 2026-04-07
## Mechanistic Overview Closed-loop focused ultrasound targeting EC-II PV interneurons to restore theta-gamma coupling a
Score: 0.857 · Alzheimer's disease · 2026-04-05
## Mechanistic Overview Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and block tau propagat
Score: 0.848 · neurodegeneration · 2026-04-13
## Mechanistic Overview p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 Phosphorylation-M
Score: 0.838 · neurodegeneration · 2026-04-17
## Mechanistic Overview Sequential Iron Chelation (Deferoxamine) and GPX4 Restoration (Sulforaphane) Prevents the Self-A
Score: 0.831 · Alzheimer's disease · 2026-04-05
## Mechanistic Overview Closed-loop tACS targeting EC-II parvalbumin interneurons to restore gamma rhythmogenesis and bl
Score: 0.827 · Alzheimer's disease · 2026-04-16
## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymph
Score: 0.820 · Alzheimer's disease · 2026-04-02
## Mechanistic Overview Hippocampal CA3-CA1 circuit rescue via neurogenesis and synaptic preservation starts from the cl
Score: 0.812 · neurodegeneration · 2026-04-17
## Mechanistic Overview SLC7A11 System Activation Restores Cystine Uptake and GSH Synthesis to Prevent Neuronal and Endo
Score: 0.803 · neurodegeneration · 2026-04-17
## Mechanistic Overview Targeting the Mechanistic Link Between AQP4 Dysfunction and Ferroptosis Prevents Both Cytotoxic
Score: 0.797 · Alzheimer's disease · 2026-04-07
## Mechanistic Overview Closed-loop transcranial focused ultrasound targeting CA1 PV interneurons with real-time gamma f
Score: 0.790 · neurodegeneration · 2026-04-22
## Mechanistic Overview NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic Axis and Dopaminergic Neuron Survival
Score: 0.790 · neurodegeneration · 2026-04-22
## Mechanistic Overview Excitatory Neuron Synaptic Dysfunction and Mitochondrial Stress via MAPT (tau) starts from the c
Score: 0.784 · Alzheimer's disease · 2026-04-05
## Mechanistic Overview Closed-loop tACS targeting entorhinal cortex layer II SST interneurons to activate AMPK-autophag